Page last updated: 2024-10-30

leflunomide and Bacterial Pneumonia

leflunomide has been researched along with Bacterial Pneumonia in 1 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bruyn, GA1
Jansen, TL1
Ten Brinke, A1
De Vries, M1
Houtman, PM1
van Roon, EN1

Other Studies

1 other study available for leflunomide and Bacterial Pneumonia

ArticleYear
Cavitating pneumonia, a severe complication of leflunomide therapy in chronic polyarthritis.
    Rheumatology (Oxford, England), 2007, Volume: 46, Issue:3

    Topics: Aged; Aged, 80 and over; Antirheumatic Agents; Female; Humans; Isoxazoles; Leflunomide; Male; Middle

2007